Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

    Investing

    • Inheritance TaxInheritance Tax
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Client Area and Conectus Portal
  • Contact Us

Market News - Page 231

28 October 2022

GSK plc- EMA Validates MAA for Cabotegravir LA for PrEP

European Medicines Agency validates ViiV Healthcare’s marketing authorisation application for cabotegravir long-acting injectable for HIV Prevention · The marketing application is based on results from…

28 October 2022

Scottish Oriental Smaller Companies Trust plc- Annual Financial Report 2022

THE SCOTTISH ORIENTAL SMALLER COMPANIES TRUST PLC Annual Financial Report for the year ended 31 August 2022 Financial Highlights Total Return Performance for the…

28 October 2022

Centrica Re-Opens Rough Storage Facility

28 October 2022 Centrica re-opens Rough storage facility Rough operational for Winter and increases UK’s storage capacity by 50% Centrica has announced the reopening…

28 October 2022

NatWest Group Q3 Interim Management Statement

NatWest Group plc Q3 2022 Interim Management Statement Chief Executive, Alison Rose, commented: “In a challenging environment, NatWest Group continues to deliver a strong…

27 October 2022

GSK plc Announces FDA Meeting Outcome on Daprodustat

GSK reports outcome from US FDA Advisory Committee meeting on daprodustat for anaemia of CKD GSK plc (LSE/NYSE: GSK) today reports that the US…

27 October 2022

GSK plc ContRAst Phase III Programme for Otilimab Update

GSK provides update on ContRAst phase III programme for otilimab in the treatment of moderate to severerheumatoid arthritis GSK plc (LSE/NYSE: GSK) today provided…

27 October 2022

Hargreaves Services plc AGM Statement

Hargreaves Services plc (“Hargreaves” or the “Group”) AGM Statement Hargreaves Services plc (AIM: HSP), a diversified group delivering services to the industrial and property sectors,…

27 October 2022

Renishaw plc Trading Statement to September 2022

Renishaw plc Trading update 27 October 2022 Renishaw plc, the global provider of manufacturing technologies, analytical instruments and medical devices, publishes this trading update…

Posts navigation

  • «
  • 1
  • …
  • 229
  • 230
  • 231
  • 232
  • 233
  • …
  • 853
  • »

Home > Market News > Page 231

James Sharp white Logo
Sign In
X Twitter Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

X Twitter Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Client Area and Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© Copyright 2010-2025. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG